Search results for "interleukin-1 beta"

showing 2 items of 2 documents

Interleukin-6 and Lymphocyte Count Associated and Predicted the Progression of Frailty Syndrome in Prostate Cancer Patients Undergoing Antiandrogen T…

2020

Frailty syndrome is a functional state that includes a loss of ability to react to stressors, and is associated with poor outcomes, morbidity and premature mortality. The first line treatment in many men with prostate cancer (PCa) consists of an androgen-deprivation therapy (ADT) which can promote or favor frailty syndrome and ADT may therefore favor the progression of frailty over time. Among the pathophysiological bases of frailty, the presence of chronic low-grade inflammation has been associated with its adverse outcomes, but longitudinal studies are needed to validate these biomarkers. In this study, we prospectively evaluate frailty syndrome and blood inflammatory markers (IL1-beta, I…

0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyleukocytesgeriatric assessmentLymphocyteFrailty syndromeInflammationinterleukin-1 betalcsh:RC254-282Article03 medical and health sciencesProstate cancer0302 clinical medicineInternal medicinemedicineInterleukin 6Receiver operating characteristicbiologybusiness.industryinterleukin-6C-reactive proteinlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.disease030104 developmental biologymedicine.anatomical_structureOncologyinflammation030220 oncology & carcinogenesisbiology.proteinBiomarker (medicine)biomarkermedicine.symptombusinessCancers
researchProduct

Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response i…

2008

André Tadic1, Dan Rujescu2, Matthias J Müller3, Ralf Kohnen4, Hans H. Stassen5, Armin Szegedi6, Norbert Dahmen11Department of Psychiatry, University of Mainz, Germany; 2Department of Psychiatry, University of Munich, Germany; 3Clinic for Psychiatry and Psychotherapy, Marburg-Sued, Germany, and Clinic for Psychiatry and Psychotherapy, Giessen, Germany; 4IMEREM, Nuernberg, Germany; 5Department of Psychiatry, University of Zurich, Switzerland; 6Organon, Roseland, NJ, USAAbstract: This study investigated the possible association of the interleukin-1 beta (IL-1β) C-511T promoter polymorphism and the interleukin-1 receptor antagonist (IL-1Ra) (86bp)n variable number o…

Neuropsychiatric Disease and Treatmentbusiness.industryMirtazapine610 Medicine & healthPharmacologyinterleukin-1 betaParoxetineantidepressive agentsPsychiatry and Mental healthVariable number tandem repeatInterleukin 1 receptor antagonistgenetic polymorphismsPolymorphism (computer science)10054 Clinic for Psychiatry Psychotherapy and Psychosomaticstreatment outcomeMedicineAntidepressantinterleukin-1 receptor antagonistmajor depressionbusinessBiological PsychiatryPharmacogeneticsOriginal ResearchGenetic associationmedicine.drug
researchProduct